Santori & Peters Inc’s Abiomed Inc ABMD Stock Holding History

Santori & Peters Inc’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35	Closed	-$8K	–	570
2017 Q4	$8K	Buy	+35	New	+$6.54K	0.01%	360

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Santori & Peters Inc's ABMD Position: Q1 2018 in Review

Santori & Peters Inc sold out of Abiomed Inc (ABMD) in Q1 2018, closing a stake of 35 shares — an estimated $8K sold.

Santori & Peters Inc first reported a position in ABMD in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 405 funds tracked by Wall St. Rank hold ABMD as of Q1 2018.

Santori & Peters Inc reported no remaining Abiomed Inc position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 35 Abiomed Inc shares in Q1 2018, an estimated $8K.
Santori & Peters Inc first reported a position in Abiomed Inc in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's Abiomed Inc position peaked at $8K in Q4 2017.
405 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.